Truist analyst David MacDonald keeps a Buy rating and $365 price target on Molina Healthcare (MOH) after the company announced that it has entered into a definitive agreement to acquire Bright Health Group’s (BHG) Medicare business in California for $510M. The firm remains positive on the company’s strong positioning around M&A and believes that the deal further validates the company’s repeatable strategy of acquiring and improving complementary assets with attractive synergy opportunities, the analyst tells investors in a research note.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOH: